163 related articles for article (PubMed ID: 29441342)
1. Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre.
Nguyen V; Li J; Gan J; Cordero P; Ray S; Solis-Cuevas A; Khatib M; Oben JA
Can J Gastroenterol Hepatol; 2017; 2017():4697194. PubMed ID: 29441342
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.
Popov VB; Thompson CC; Kumar N; Ciarleglio MM; Deng Y; Laine L
Dig Dis Sci; 2016 Sep; 61(9):2477-87. PubMed ID: 27207181
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis.
Chandan S; Mohan BP; Khan SR; Facciorusso A; Ramai D; Kassab LL; Bhogal N; Asokkumar R; Lopez-Nava G; McDonough S; Adler DG
Obes Surg; 2021 Mar; 31(3):1271-1279. PubMed ID: 33409973
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity.
Aoko O; Maharaj T; Boland F; Cheriyan D; Ryan J
Aliment Pharmacol Ther; 2024 Jan; 59(1):8-22. PubMed ID: 37986213
[TBL] [Abstract][Full Text] [Related]
5. Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis.
Salomone F; Currenti W; Magrì G; Boškoski I; Zelber-Sagi S; Galvano F
Liver Int; 2021 Sep; 41(9):2112-2116. PubMed ID: 33938630
[TBL] [Abstract][Full Text] [Related]
6. Intragastric Balloon Treatment for Obesity: Review of Recent Studies.
Tate CM; Geliebter A
Adv Ther; 2017 Aug; 34(8):1859-1875. PubMed ID: 28707286
[TBL] [Abstract][Full Text] [Related]
7. Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis.
Bazerbachi F; Vargas EJ; Rizk M; Maselli DB; Mounajjed T; Venkatesh SK; Watt KD; Port JD; Basu R; Acosta A; Hanouneh I; Gara N; Shah M; Mundi M; Clark M; Grothe K; Storm AC; Levy MJ; Abu Dayyeh BK
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):146-154.e4. PubMed ID: 32360804
[TBL] [Abstract][Full Text] [Related]
8. Comparative Study of Intragastric Balloon and Cognitive-Behavioral Approach for Non-Morbid Obesity.
Majanovic SK; Ruzic A; Bulian AP; Licul V; Orlic ZC; Stimac D
Hepatogastroenterology; 2014 Jun; 61(132):937-41. PubMed ID: 26158145
[TBL] [Abstract][Full Text] [Related]
9. Comparison of results of laparoscopic gastric banding and consecutive intragastric balloon application at 18 months: a clinical prospective study.
Peker Y; Coskun H; Bozkurt S; Cin N; Atak T; Genc H
J Laparoendosc Adv Surg Tech A; 2011; 21(6):471-5. PubMed ID: 21612448
[TBL] [Abstract][Full Text] [Related]
10. Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding.
Folini L; Veronelli A; Benetti A; Pozzato C; Cappelletti M; Masci E; Micheletto G; Pontiroli AE
Acta Diabetol; 2014; 51(3):361-8. PubMed ID: 24085682
[TBL] [Abstract][Full Text] [Related]
11. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
Mager DR; Iñiguez IR; Gilmour S; Yap J
JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
[TBL] [Abstract][Full Text] [Related]
12. Intragastric Balloon for Management of Severe Obesity: a Systematic Review.
Yorke E; Switzer NJ; Reso A; Shi X; de Gara C; Birch D; Gill R; Karmali S
Obes Surg; 2016 Sep; 26(9):2248-2254. PubMed ID: 27444806
[TBL] [Abstract][Full Text] [Related]
13. Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
Vijayaraghavan R; Sarin SK; Bharadwaj A; Anand L; Maiwall R; Choudhury A; Benjamin J; Kanal U; Jamwal KD
Dig Dis Sci; 2023 Mar; 68(3):1035-1041. PubMed ID: 35763235
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Weight Loss With the Intragastric Balloon in Patients With Different Degrees of Obesity.
Nunes GC; Pajecki D; de Melo ME; Mancini MC; de Cleva R; Santo MA
Surg Laparosc Endosc Percutan Tech; 2017 Aug; 27(4):e83-e86. PubMed ID: 28731953
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of First-Time Intragastric Balloon in Weight Loss: a Systematic Review and Meta-analysis of Randomized Controlled Trials.
Saber AA; Shoar S; Almadani MW; Zundel N; Alkuwari MJ; Bashah MM; Rosenthal RJ
Obes Surg; 2017 Feb; 27(2):277-287. PubMed ID: 27465936
[TBL] [Abstract][Full Text] [Related]
16. Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study.
Cortés V; Quezada N; Uribe S; Arrese M; Nervi F
Lipids Health Dis; 2017 Jun; 16(1):129. PubMed ID: 28666456
[TBL] [Abstract][Full Text] [Related]
17. Does combining liraglutide with intragastric balloon insertion improve sustained weight reduction?
Mosli MM; Elyas M
Saudi J Gastroenterol; 2017; 23(2):117-122. PubMed ID: 28361843
[TBL] [Abstract][Full Text] [Related]
18. Intragastric balloon in the treatment of patients with morbid obesity.
Evans JD; Scott MH
Br J Surg; 2001 Sep; 88(9):1245-8. PubMed ID: 11531875
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
Cordeiro A; Pereira SE; Saboya CJ; Ramalho A
Biomed Res Int; 2015; 2015():839253. PubMed ID: 26120587
[TBL] [Abstract][Full Text] [Related]
20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
